Organothiophosphorus Compounds
"Organothiophosphorus Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds containing carbon-phosphorus bonds in which the phosphorus component is also bonded to one or more sulfur atoms. Many of these compounds function as CHOLINERGIC AGENTS and as INSECTICIDES.
Descriptor ID |
D009946
|
MeSH Number(s) |
D02.705.539 D02.886.300
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Organothiophosphorus Compounds".
Below are MeSH descriptors whose meaning is more specific than "Organothiophosphorus Compounds".
This graph shows the total number of publications written about "Organothiophosphorus Compounds" by people in this website by year, and whether "Organothiophosphorus Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Organothiophosphorus Compounds" by people in Profiles.
-
Warnecke JM, Sontheimer EJ, Piccirilli JA, Hartmann RK. Active site constraints in the hydrolysis reaction catalyzed by bacterial RNase P: analysis of precursor tRNAs with a single 3'-S-phosphorothiolate internucleotide linkage. Nucleic Acids Res. 2000 Feb 01; 28(3):720-7.
-
Ryder SP, Ortoleva-Donnelly L, Kosek AB, Strobel SA. Chemical probing of RNA by nucleotide analog interference mapping. Methods Enzymol. 2000; 317:92-109.
-
Mantle D, Saleem MA, Williams FM, Wilkins RM, Shakoori AR. Effect of pirimiphos-methyl on proteolytic enzyme activities in rat heart, kidney, brain and liver tissues in vivo. Clin Chim Acta. 1997 Jun 27; 262(1-2):89-97.
-
Shaw LM, Glover D, Turrisi A, Brown DQ, Bonner HS, Norfleet AL, Weiler C, Glick JH, Kligerman MM. Pharmacokinetics of WR-2721. Pharmacol Ther. 1988; 39(1-3):195-201.
-
Brown DQ, Graham WJ, MacKenzie LJ, Pittock JW, Shaw LM. Can WR-2721 be improved upon? Pharmacol Ther. 1988; 39(1-3):157-68.
-
Nakamura J, Shaw LM, Brown DQ. Hydrolysis of WR2721 by mouse liver cell fractions. Radiat Res. 1987 Jan; 109(1):143-52.
-
Shaw LM, Turrisi AT, Glover DJ, Bonner HS, Norfleet AL, Weiler C, Kligerman MM. Human pharmacokinetics of WR-2721. Int J Radiat Oncol Biol Phys. 1986 Aug; 12(8):1501-4.
-
Risley JM, Van Etten RL, Shaw LM, Bonner H. Hydrolysis of S-2-(3-aminopropylamino)ethylphosphorothioate (WR-2721). Biochem Pharmacol. 1986 May 01; 35(9):1453-8.